These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 8760797

  • 1. Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens.
    Dudley ME, Roopenian DC.
    J Exp Med; 1996 Aug 01; 184(2):441-7. PubMed ID: 8760797
    [Abstract] [Full Text] [Related]

  • 2. Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines.
    Kono K, Petersson M, Ciupitu AM, Wen T, Klein G, Kiessling R.
    Cancer Res; 1995 Dec 01; 55(23):5648-55. PubMed ID: 7585649
    [Abstract] [Full Text] [Related]

  • 3. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
    Pérez M, Garrido A, Algarra I, Caballero A, Delgado C, Collado MD, Fernández-Cruz E, Garrido F.
    Exp Clin Immunogenet; 1989 Dec 01; 6(3):204-18. PubMed ID: 2631798
    [Abstract] [Full Text] [Related]

  • 4. Characterization of cloned class I MHC-restricted, CD8+ anti-Meth A cytotoxic T-lymphocytes: recognition of an epitope derived from the Meth A gp110 tumor rejection antigen.
    Fassanito MA, Loftus D, De Leo RM, Law LW, Appella E, De Leo AB.
    Cancer Res; 1994 Aug 15; 54(16):4424-9. PubMed ID: 7519121
    [Abstract] [Full Text] [Related]

  • 5. Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro.
    Van Waes C, Monach PA, Urban JL, Wortzel RD, Schreiber H.
    Tissue Antigens; 1996 May 15; 47(5):399-407. PubMed ID: 8795140
    [Abstract] [Full Text] [Related]

  • 6. Efficient chromosomal mapping of a methylcholanthrene-induced tumor antigen by CTL immunoselection.
    Akilesh S, Dudley ME, Eden PA, Roopenian DC.
    J Immunol; 2001 Nov 01; 167(9):5143-9. PubMed ID: 11673526
    [Abstract] [Full Text] [Related]

  • 7. Cell surface antigens of murine leukemias induced by radiation leukemia virus. Recognition of individually distinct cell surface antigens by cytotoxic T cells on leukemias expressing crossreactive transplantation antigens.
    Morishita H, Shiku H, Horibe K, Obata Y, Stockert E, Oettgen HF, Old LJ, Yamada K.
    J Exp Med; 1986 Feb 01; 163(2):452-7. PubMed ID: 3003228
    [Abstract] [Full Text] [Related]

  • 8. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones.
    Maryanski JL, Boon T.
    Eur J Immunol; 1982 May 01; 12(5):406-12. PubMed ID: 6178608
    [Abstract] [Full Text] [Related]

  • 9. CD4+ T-cells from mice immunized to syngeneic sarcomas recognize distinct, non-shared tumor antigens.
    Cohen PA, Cohen PJ, Rosenberg SA, Mulé JJ.
    Cancer Res; 1994 Feb 15; 54(4):1055-8. PubMed ID: 7906197
    [Abstract] [Full Text] [Related]

  • 10. Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyte.
    Frassanito MA, Mayordomo JI, DeLeo RM, Storkus WJ, Lotze MT, DeLeo AB.
    Cancer Res; 1995 Jan 01; 55(1):124-8. PubMed ID: 7528638
    [Abstract] [Full Text] [Related]

  • 11. Changes in tumor-specific antigen expression during passage in vitro and in vivo of newly derived methylcholanthrene-induced sarcomas of BALB/C mice.
    Law LW.
    Int J Cancer; 1980 Feb 15; 25(2):251-9. PubMed ID: 6156130
    [Abstract] [Full Text] [Related]

  • 12. The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product.
    Huang AY, Gulden PH, Woods AS, Thomas MC, Tong CD, Wang W, Engelhard VH, Pasternack G, Cotter R, Hunt D, Pardoll DM, Jaffee EM.
    Proc Natl Acad Sci U S A; 1996 Sep 03; 93(18):9730-5. PubMed ID: 8790399
    [Abstract] [Full Text] [Related]

  • 13. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ, Wheelock EF.
    Cancer Res; 1982 Sep 03; 42(9):3607-16. PubMed ID: 6179603
    [Abstract] [Full Text] [Related]

  • 14. H-2K restriction of the T cell-mediated lysis of a chemically-induced BALB/c fibrosarcoma.
    Colombo MP, Rodolfo M, Parmiani G.
    J Immunogenet; 1983 Aug 03; 10(4):337-40. PubMed ID: 6604758
    [Abstract] [Full Text] [Related]

  • 15. B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes.
    Johnston JV, Malacko AR, Mizuno MT, McGowan P, Hellström I, Hellström KE, Marquardt H, Chen L.
    J Exp Med; 1996 Mar 01; 183(3):791-800. PubMed ID: 8642283
    [Abstract] [Full Text] [Related]

  • 16. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
    Yannelli JR, Moore LC, Engelhard VH.
    J Immunol; 1985 Aug 01; 135(2):900-5. PubMed ID: 2409157
    [Abstract] [Full Text] [Related]

  • 17. Expression of a shared tumor-specific antigen by two chemically induced BALB/c sarcomas.
    Palladino MA, Srivastava PK, Oettgen HF, DeLeo AB.
    Cancer Res; 1987 Oct 01; 47(19):5074-9. PubMed ID: 3497717
    [Abstract] [Full Text] [Related]

  • 18. Expansion of tumor-specific cytolytic T lymphocytes using in vitro restimulation with tumor-specific transplantation antigen.
    Naito K, Pellis NR, Kahan BD.
    Cell Immunol; 1987 Sep 01; 108(2):483-94. PubMed ID: 3113743
    [Abstract] [Full Text] [Related]

  • 19. Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma.
    DeLeo AB, Shiku H, Takahashi T, John M, Old LJ.
    J Exp Med; 1977 Sep 01; 146(3):720-34. PubMed ID: 197192
    [Abstract] [Full Text] [Related]

  • 20. Recurrent T cell receptor rearrangements in the cytotoxic T lymphocyte response in vivo against the p815 murine tumor.
    Levraud JP, Pannetier C, Langlade-Demoyen P, Brichard V, Kourilsky P.
    J Exp Med; 1996 Feb 01; 183(2):439-49. PubMed ID: 8627157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.